345 related articles for article (PubMed ID: 22620684)
1. Clinical improvement and satisfaction with biologic therapy in patients with severe plaque psoriasis: results of a European cross-sectional observational study.
Christophers E; Segaert S; Milligan G; Molta CT; Boggs R
J Dermatolog Treat; 2013 Jun; 24(3):193-8. PubMed ID: 22620684
[TBL] [Abstract][Full Text] [Related]
2. Treatment patterns in moderate-to-severe plaque psoriasis: results from a Belgian cross-sectional study (DISCOVER).
Lambert J; Ghislain PD; Lambert J; Cauwe B; Van den Enden M
J Dermatolog Treat; 2017 Aug; 28(5):394-400. PubMed ID: 27791446
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacy of biologics versus conventional systemic therapies in the treatment of psoriasis at a comprehensive psoriasis care center.
Au SC; Madani A; Alhaddad M; Alkofide M; Gottlieb AB
J Drugs Dermatol; 2013 Aug; 12(8):861-6. PubMed ID: 23986158
[TBL] [Abstract][Full Text] [Related]
4. Biologic and Conventional Systemic Therapies Show Similar Safety and Efficacy in Elderly and Adult Patients With Moderate to Severe Psoriasis.
Garber C; Plotnikova N; Au SC; Sorensen EP; Gottlieb A
J Drugs Dermatol; 2015 Aug; 14(8):846-52. PubMed ID: 26267729
[TBL] [Abstract][Full Text] [Related]
5. Defining and treating moderate plaque psoriasis: a dermatologist survey.
Knuckles MLF; Levi E; Soung J
J Dermatolog Treat; 2018 Nov; 29(7):658-663. PubMed ID: 29502473
[TBL] [Abstract][Full Text] [Related]
6. Clearance of psoriasis: the impact of private versus public insurance.
Buzney CD; Peterman C; Saraiya A; Au SC; Dumont N; Mansfield R; Gottlieb AB
J Drugs Dermatol; 2015 Feb; 14(2):119-25. PubMed ID: 25689806
[TBL] [Abstract][Full Text] [Related]
7. Satisfaction with current psoriasis treatment: misalignment between physician and patient perceptions.
Korman NJ; Zhao Y; Pike J; Roberts J; Sullivan E; Kemhus M
Dermatol Online J; 2016 Jul; 22(7):. PubMed ID: 27617714
[TBL] [Abstract][Full Text] [Related]
8. Treatment patterns with topicals, traditional systemics and biologics in psoriasis - a Swedish database analysis.
Svedbom A; Dalén J; Mamolo C; Cappelleri JC; Petersson IF; Ståhle M
J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):215-223. PubMed ID: 24813476
[TBL] [Abstract][Full Text] [Related]
9. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation.
Armstrong AW; Bagel J; Van Voorhees AS; Robertson AD; Yamauchi PS
JAMA Dermatol; 2015 Apr; 151(4):432-8. PubMed ID: 25517130
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of Biologic and Conventional Systemic Therapies in Adults with Chronic Plaque Psoriasis in Daily Practice: A Systematic Review.
Zweegers J; Otero ME; van den Reek JM; van Lümig PP; Driessen RJ; Kievit W; Seyger MM; van de Kerkhof PC; de Jong EM
Acta Derm Venereol; 2016 May; 96(4):453-8. PubMed ID: 26537336
[TBL] [Abstract][Full Text] [Related]
11. Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practice.
Duffin KC; Yeung H; Takeshita J; Krueger GG; Robertson AD; Troxel AB; Shin DB; Van Voorhees AS; Gelfand JM
Br J Dermatol; 2014 Mar; 170(3):672-680. PubMed ID: 24266717
[TBL] [Abstract][Full Text] [Related]
12. Satisfaction with treatment among patients with psoriasis: a web-based survey study.
van Cranenburgh OD; de Korte J; Sprangers MA; de Rie MA; Smets EM
Br J Dermatol; 2013 Aug; 169(2):398-405. PubMed ID: 23565643
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis.
Bissonnette R; Kerdel F; Naldi L; Papp K; Galindo C; Langholff W; Tang KL; Szapary P; Fakharzadeh S; Srivastava B; Goyal K; Gottlieb AB
J Drugs Dermatol; 2017 Oct; 16(10):1002-1013. PubMed ID: 29036254
[TBL] [Abstract][Full Text] [Related]
14. Disease and treatment burden of psoriasis: examining the impact of biologics.
Raval K; Lofland JH; Waters H; Piech CT
J Drugs Dermatol; 2011 Feb; 10(2):189-96. PubMed ID: 21283925
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Phototherapy in the Age of Biologics.
Calzavara-Pinton P; Zanca A; Arisi M; Rossi MT; Zane C; Venturini M; Ortel B
Dermatology; 2018; 234(5-6):166-172. PubMed ID: 30205372
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Management Guidelines for Moderate-to-Severe Plaque Psoriasis: A Review of Phototherapy, Systemic Therapies, and Biologic Agents.
Ighani A; Partridge ACR; Shear NH; Lynde C; Gulliver WP; Sibbald C; Fleming P
J Cutan Med Surg; 2019; 23(2):204-221. PubMed ID: 30463416
[TBL] [Abstract][Full Text] [Related]
17. A comparison of psoriasis drug failure rates and reasons for discontinuation in biologics vs conventional systemic therapies.
Levin AA; Gottlieb AB; Au SC
J Drugs Dermatol; 2014 Jul; 13(7):848-53. PubMed ID: 25007369
[TBL] [Abstract][Full Text] [Related]
18. Rationale, objectives and design of PURE, a prospective registry of patients with moderate to severe chronic plaque psoriasis in Canada and Latin America.
Papp KA; Gooderham M; Beecker J; Lynde CW; Delorme I; Dei-Cas I; Albrecht L; Rampakakis E; Sampalis JS; Vieira A; Hussein S; Chambenoit O; Rihakova L
BMC Dermatol; 2019 Jun; 19(1):9. PubMed ID: 31226985
[TBL] [Abstract][Full Text] [Related]
19. The Evolving Landscape of Psoriasis Treatment.
Armstrong AW; Gordon KB; Menter MA; Wu JJ
Semin Cutan Med Surg; 2018 Feb; 37(2S):S39-S43. PubMed ID: 29614136
[TBL] [Abstract][Full Text] [Related]
20. Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR).
Strober B; Gooderham M; de Jong EMGJ; Kimball AB; Langley RG; Lakdawala N; Goyal K; Lawson F; Langholff W; Hopkins L; Fakharzadeh S; Srivastava B; Menter A
J Am Acad Dermatol; 2018 Jan; 78(1):70-80. PubMed ID: 29102053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
